Literature DB >> 1318418

Myristylation of poliovirus capsid precursor P1 is required for assembly of subviral particles.

D C Ansardi1, D C Porter, C D Morrow.   

Abstract

The poliovirus capsid precursor polyprotein, P1, is cotranslationally modified by the addition of myristic acid. We have examined the importance of myristylation of the P1 capsid precursor during the poliovirus assembly process by using a recently described recombinant vaccinia virus expression system which allows the independent production of the poliovirus P1 protein and the poliovirus 3CD proteinase (D. C. Ansardi, D. C. Porter, and C. D. Morrow, J. Virol. 65:2088-2092, 1991). We constructed a site-directed mutation in the poliovirus cDNA encoding an alanine at the second amino acid position of P1 in place of the glycine residue required for the myristic acid addition and isolated a recombinant vaccinia virus (VVP1myr-) that expressed a nonmyristylated form of the P1 capsid precursor. The 3CD proteinase expressed by a coinfecting vaccinia virus, VVP3, proteolytically processed the nonmyristylated precursor P1 expressed by VVP1myr-. However, the processed capsid proteins, VP0, VP3, and VP1, did not assemble into 14S or 75S subviral particles, in contrast to the VP0, VP3, and VP1 proteins derived from the myristylated P1 precursor. When cells were coinfected with VVP1myr- and poliovirus type 1, the nonmyristylated P1 precursor expressed by VVP1myr- was processed by 3CD expressed by poliovirus, and the nonmyristylated VP0-VP3-VP1 (VP0-3-1) protomers were incorporated into capsid particles and virions which sedimented through a 30% sucrose cushion. Thus, the nonmyristylated P1 precursor and VP0-3-1 protomers were not excluded from sites of virion assembly, and the assembly defects observed for the nonmyristylated protomers were overcome in the presence of myristylated capsid protomers expressed by poliovirus. We conclude that myristylation of the poliovirus P1 capsid precursor plays an important role during poliovirus assembly by facilitating the appropriate interactions required between 5S protomer subunits to form stable 14S pentamers. The results of these studies demonstrate that the independent expression of the poliovirus P1 and 3CD proteins by using recombinant vaccinia viruses provides a unique experimental tool for analyzing the dynamics of the poliovirus assembly process.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1318418      PMCID: PMC241268     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  31 in total

1.  Functional analysis of protein N-myristoylation: metabolic labeling studies using three oxygen-substituted analogs of myristic acid and cultured mammalian cells provide evidence for protein-sequence-specific incorporation and analog-specific redistribution.

Authors:  D R Johnson; A D Cox; P A Solski; B Devadas; S P Adams; R M Leimgruber; R O Heuckeroth; J E Buss; J I Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1990-11       Impact factor: 11.205

2.  An assembly defect as a result of an attenuating mutation in the capsid proteins of the poliovirus type 3 vaccine strain.

Authors:  A J Macadam; G Ferguson; C Arnold; P D Minor
Journal:  J Virol       Date:  1991-10       Impact factor: 5.103

3.  A Gly1 to Ala substitution in poliovirus capsid protein VP0 blocks its myristoylation and prevents viral assembly.

Authors:  D Marc; M Girard; S van der Werf
Journal:  J Gen Virol       Date:  1991-05       Impact factor: 3.891

4.  Myristoylation is important at multiple stages in poliovirus assembly.

Authors:  N Moscufo; J Simons; M Chow
Journal:  J Virol       Date:  1991-05       Impact factor: 5.103

5.  Lack of myristoylation of poliovirus capsid polypeptide VP0 prevents the formation of virions or results in the assembly of noninfectious virus particles.

Authors:  D Marc; G Masson; M Girard; S van der Werf
Journal:  J Virol       Date:  1990-09       Impact factor: 5.103

6.  Limited expression of poliovirus by vaccinia virus recombinants due to inhibition of the vector by proteinase 2A.

Authors:  J E Jewell; L A Ball; R Rueckert
Journal:  J Virol       Date:  1990-03       Impact factor: 5.103

7.  Myristoylation-dependent replication and assembly of human immunodeficiency virus 1.

Authors:  M Bryant; L Ratner
Journal:  Proc Natl Acad Sci U S A       Date:  1990-01       Impact factor: 11.205

Review 8.  Picornaviral structure and assembly.

Authors:  J R Putnak; B A Phillips
Journal:  Microbiol Rev       Date:  1981-06

9.  Myristoylation of the poliovirus polyprotein is required for proteolytic processing of the capsid and for viral infectivity.

Authors:  H G Kräusslich; C Hölscher; Q Reuer; J Harber; E Wimmer
Journal:  J Virol       Date:  1990-05       Impact factor: 5.103

10.  Interaction of Hsp 70 with newly synthesized proteins: implications for protein folding and assembly.

Authors:  R P Beckmann; L E Mizzen; W J Welch
Journal:  Science       Date:  1990-05-18       Impact factor: 47.728

View more
  28 in total

Review 1.  Foot-and-mouth disease.

Authors:  Marvin J Grubman; Barry Baxt
Journal:  Clin Microbiol Rev       Date:  2004-04       Impact factor: 26.132

Review 2.  Expanding knowledge of P3 proteins in the poliovirus lifecycle.

Authors:  Craig E Cameron; Hyung Suk Oh; Ibrahim M Moustafa
Journal:  Future Microbiol       Date:  2010-06       Impact factor: 3.165

3.  Intramolecular and intermolecular uridylylation by poliovirus RNA-dependent RNA polymerase.

Authors:  Oliver C Richards; Jeannie F Spagnolo; John M Lyle; Susan E Vleck; Robert D Kuchta; Karla Kirkegaard
Journal:  J Virol       Date:  2006-08       Impact factor: 5.103

Review 4.  Picornavirus morphogenesis.

Authors:  Ping Jiang; Ying Liu; Hsin-Chieh Ma; Aniko V Paul; Eckard Wimmer
Journal:  Microbiol Mol Biol Rev       Date:  2014-09       Impact factor: 11.056

5.  Using recombinant coxsackievirus B3 to evaluate the induction and protective efficacy of CD8+ T cells during picornavirus infection.

Authors:  M K Slifka; R Pagarigan; I Mena; R Feuer; J L Whitton
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

6.  Structure, Immunogenicity, and Protective Mechanism of an Engineered Enterovirus 71-Like Particle Vaccine Mimicking 80S Empty Capsid.

Authors:  Xiaoli Wang; Zhiqiang Ku; Xiang Zhang; Xiaohua Ye; Jinhuan Chen; Qingwei Liu; Wei Zhang; Chao Zhang; Zhenglin Fu; Xia Jin; Yao Cong; Zhong Huang
Journal:  J Virol       Date:  2017-12-14       Impact factor: 5.103

7.  Foot-and-mouth disease virus 2A protease mediates cleavage in attenuated Sabin 3 poliovirus vectors engineered for delivery of foreign antigens.

Authors:  N M Mattion; E C Harnish; J C Crowley; P A Reilly
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

8.  Release of virus-like particles from cells infected with poliovirus replicons which express human immunodeficiency virus type 1 Gag.

Authors:  D C Porter; L R Melsen; R W Compans; C D Morrow
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

9.  Poliovirus capsid proteins derived from P1 precursors with glutamine-valine cleavage sites have defects in assembly and RNA encapsidation.

Authors:  D C Ansardi; C D Morrow
Journal:  J Virol       Date:  1993-12       Impact factor: 5.103

10.  Foot-and-mouth disease virus assembly: processing of recombinant capsid precursor by exogenous protease induces self-assembly of pentamers in vitro in a myristoylation-dependent manner.

Authors:  Stewart Goodwin; Tobias J Tuthill; Armando Arias; Richard A Killington; David J Rowlands
Journal:  J Virol       Date:  2009-08-26       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.